Hydroxyurea and Everolimus drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Hydroxyurea (hydroxyurea) and Everolimus (everolimus). Common drug interactions include hepatosplenic candidiasis among females and blood sodium decreased among males.

The phase IV clinical study analyzes what interactions people have when they take Hydroxyurea and Everolimus. It is created by eHealthMe based on reports of 11 people who take the same drugs from the FDA, and is updated regularly.

What is Hydroxyurea?

Hydroxyurea has active ingredients of hydroxyurea. It is often used in polycythemia vera. eHealthMe is studying from 17,240 Hydroxyurea users. Check the latest studies of Hydroxyurea.

What is Everolimus?

Everolimus has active ingredients of everolimus. eHealthMe is studying from 16,228 Everolimus users. Check the latest studies of Everolimus.

On Jul, 21, 2026

11 people who take Hydroxyurea and Everolimus together, and have interactions are studied.

Hydroxyurea and Everolimus drug interactions.

What are the common drug interactions of Hydroxyurea and Everolimus, by gender? *:

female:

Hepatosplenic candidiasis (fungal infection in liver and spleen)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pericarditis (inflammation of the pericardium)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Septic shock (shock due to blood infection)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Neoplasm progression (growth of tumour)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

male:

Blood sodium decreased
Cellulitis (infection under the skin)
Loss of consciousness
Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Drug ineffective

What are the common drug interactions of Hydroxyurea and Everolimus, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
Cellulitis (infection under the skin)
Hepatosplenic candidiasis (fungal infection in liver and spleen)
Myelodysplastic syndrome (a group of conditions that occur when the blood-forming cells in the bone marrow are damaged)
Pericarditis (inflammation of the pericardium)
Posterior reversible encephalopathy syndrome (posterior reversible encephalopathy syndrome (pres), also known as reversible posterior leukoencephalopathy syndrome (rpls), is a syndrome characterized by headache, confusion, seizures and visual loss)
Septic shock (shock due to blood infection)
Pneumonia klebsiella (pneumonia caused by bacteria klebsiella)
Klebsiella sepsis (klebsiella causes a potentially fatal whole-body inflammation)
Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)

30-39:

n/a

40-49:

Blood sodium decreased
Cellulitis (infection under the skin)
Loss of consciousness
Metabolic disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues)
Pneumonia
Sepsis (a severe blood infection that can lead to organ failure and death)
Acute myeloid leukaemia recurrent (acute cancer in which the bone marrow makes abnormal myeloblast- recurrent)
Neoplasm progression (growth of tumour)

50-59:

n/a

60+:

Drug ineffective

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 7 people, 63.64%
Bone Marrow Conditioning Regimen: 6 people, 54.55%
Neoplasm Malignant (cancer tumour): 1 person, 9.09%
Meningioma (a diverse set of tumours arising from the meninges): 1 person, 9.09%
Brain Neoplasm Malignant (brain cancer tumour): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Hydroxyurea and Everolimus?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously